Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.
about
Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomesRole of mesenchymal cells in the natural history of ovarian cancer: a reviewHyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal CarcinomatosisCritical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.Hyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data.[Thermo-chemotherapy of GP or TP for advanced non-small cell lung cancer: a systematic review].Hyperthermic Intra-Thoracic Chemotherapy (HITeC) for the management of recurrent ovarian cancer involving the pleural cavity.Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials.Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational studyCytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis.Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer.Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patientsIntraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy.Depth of colorectal-wall invasion and lymph-node involvement as major outcome factors influencing surgical strategy in patients with advanced and recurrent ovarian cancer with diffuse peritoneal metastasesOutcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasmsCytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.Small bowel emergency surgery: literature's reviewThe role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC).Oncology imaging in the abdomen and pelvis: where cancer hides.The changing landscape of therapeutic strategies for recurrent ovarian cancer.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: where are we?Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review.Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models.Surgical treatment of peritoneal carcinomatosis: current treatment modalities.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality.Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.Radical surgery in ovarian cancer.Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer.A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis.Intraperitoneal paclitaxel induces regression of peritoneal metastasis partly by destruction of peripheral microvessels.Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites.Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis.Prognostic factors of intraperitoneal chemotherapy for peritoneal carcinomatosis of gastric cancer: A retrospective study from a single center.
P2860
Q26768299-D6B23A6B-7782-402B-94DA-39902E54E8DAQ26823555-1F37C155-54E4-414F-A11D-118DBB4BE271Q28077394-9DBC493D-EB61-4220-ADE4-EAD76F935361Q33634993-E7193D8D-666C-41E0-9044-906F444380C2Q34046589-81E1D667-164A-45E0-860F-AAC0D3B85524Q34356395-B35A07CF-0242-4650-9707-5C875031F05FQ34383545-9C48B6B5-443C-48E8-925E-308B8EC38E1CQ34561445-42900029-67BE-4BA7-B3D9-024280016839Q34590558-2250DD67-B731-4CB6-976B-C2E10484D079Q34996992-4EE8AA9D-C48D-4B26-A76E-3BAD69339594Q35817844-9C95D9EE-DE86-4CE6-84FE-56E9A359AB06Q35886105-BFEC6D56-5E27-4EF3-98A9-537E9452AA0DQ35929166-FEA89EE5-CF81-4FBE-BF26-0500E80C773FQ35955901-4047F9B9-4879-4CD9-9BAE-EF6B85E3816EQ36125424-4E5BE801-C46B-473A-967A-B52B22B4C0ADQ36444374-C4EA46E4-518F-48B5-BFDA-EE8855642912Q36691447-D7A51471-26FB-423D-A6D1-CC8C78A2A7D2Q37284434-BFC5860D-18CF-41D3-8EB2-DE67A1EE0171Q37683243-B16B64D2-BCDF-4BCF-8E3A-883433BABCAFQ37826811-EE06305C-DB8A-41CA-AC6A-FAFAE4A9F6BAQ38027027-88F7B00E-BFF7-4E04-8DF6-18C60357BD8AQ38033094-E63AD456-CD51-4C67-AE08-BB62CA07EBACQ38048887-CCB5A8D0-B2B0-43F3-8970-547D7569A920Q38053418-BE18E8DD-0A02-46F7-9322-6FB08B8EB942Q38090517-F12D7BFF-5CDE-459D-B0F4-103B4F86ABFFQ38105057-235FDB45-0AD7-4548-BD35-D54F760BE02BQ38152303-B606DDB5-B9A3-421E-80DB-1811E3B32AB8Q38163913-20C18CA7-4C58-4480-9B37-0FC9AB8CE178Q38243089-F1CA541B-616F-43EE-98C1-8D7ED998A39BQ38244051-C4B7BA44-47C1-422A-813E-12DD58D42CEFQ38364615-E045AF8B-9355-489E-848B-2B442FAA9894Q38645300-AE65D3FD-AA51-4905-8183-ED615270402CQ38684738-878C3ADC-6948-48F3-8B9B-98293A5243ADQ38777716-670CF8F7-6F93-4B77-A5D3-206BC316A8DDQ38836835-B3A7B49E-B11A-4799-8A20-4566B48A54C7Q38868563-A69B67D7-CA58-459F-98E9-A7B42A0F2395Q39030522-501B7E5C-217B-4287-A342-0335B68D9E81Q39151711-9AAADB8C-70BF-4D08-B976-631441EA5B12Q40251231-7FCA203E-645F-4762-96F1-B482B8DB5590Q40496581-70D0A4F3-9270-496A-82C8-65FF488F459D
P2860
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intraoperative hyperthermic in ...... tic review of current results.
@en
Intraoperative hyperthermic in ...... tic review of current results.
@nl
type
label
Intraoperative hyperthermic in ...... tic review of current results.
@en
Intraoperative hyperthermic in ...... tic review of current results.
@nl
prefLabel
Intraoperative hyperthermic in ...... tic review of current results.
@en
Intraoperative hyperthermic in ...... tic review of current results.
@nl
P2093
P1476
Intraoperative hyperthermic in ...... tic review of current results.
@en
P2093
David L Morris
Greg Robertson
Rhonda Farrell
Terence C Chua
Tristan D Yan
Winston Liauw
P2888
P304
P356
10.1007/S00432-009-0667-4
P577
2009-08-23T00:00:00Z